Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), India

Abstract

Background and Purpose: Occurrence of stroke has been reported among patients with COVID-19. The present study compares clinical features and outcomes of stroke patients with and without COVID-19. Methods: The COVID-19 Stroke Study Group (CSSG) is a multicentric study in 18 sites across India to observe and compare the clinical characteristics of patients with stroke admitted during the current pandemic period and a similar epoch in 2019. The present study reports patients of stroke with and without COVID-19 (CoVS and non-CoVS, respectively) seen between February 2020 and July 2020. Demographic, clinical, treatment, and outcome details of patients were collected. Results: The mean age and gender were comparable between the two groups. CoVS patients had higher stroke severity and extent of cerebral involvement on imaging. In-hospital complications and death were higher among CoVS patients (53.06% vs. 17.51%; P < 0.001) and (42.31% vs. 7.6%; P < 0.001), respectively. At 3 months, higher mortality was observed among CoVS patients (67.65% vs. 13.43%; P < 0.001) and good outcome (modified Rankin score [mRS]: 0–2) was seen more often in non-CoVS patients (68.86% vs. 33.33%; P < 0.001). The presence of COVID-19 and baseline stroke severity were independent predictors of mortality. Conclusions: CoVS is associated with higher severity, poor outcome, and increased mortality. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and baseline stroke severity are independent predictors of mortality.

Assessment of Decompressive Craniectomy in Patients with Malignant Cerebral Infarction and Co-Occurring SARS-CoV-2 Infection

“…Preliminary discussions have indicated limited evidence based on case reports and small case series (Bhatia et al, 2021;Chan, Salonga, & Khu, 2021;Liang et al, 2020;Sáez-Alegre et al, 2021), suggesting a suboptimal response to this surgical approach. These findings warrant further exploration of alternative strategies.…”

Predicting mortality in hospitalized COVID-19 patients

“…Also, SARS-CoV-2 infection is associated with neuropathology [36]. Not only the infection itself is related to acute cerebral events [37] but also patients with acute stroke and COVID-19 infection have a worst prognosis [38]. The presence of an inflammatory-hypercoagulability state, together with vessel damages and blood stasis-i.e., the so-called Virchow triad-is associated with a higher risk of thrombus formation.…”

Rule out differentials before blaming SARS-CoV-2

“…There is doubt that there was a causal relation between the neurological abnormalities and SARS-CoV-2 in patient-1. Though ICH [2] , ischemic stroke stroke [3] , and VST [4] have been reported as manifestations of neuro-COVID, a clear-cut causal relation between the virus and the various neurological diseases was not unequivocally provided: the cardiovascular risk factors and the pertinent medication in patient-1should be provided. The sequence of events is unclear in patient-1.…”